Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: BOD

Dec 07, 2006 03:24PM

Ba, I agree 100%. Replace the board and the company is overhauled with new talent, new life, a vision and a move to break away from the old past leadership and schwartz. read the bios of the BOD and evaluate what they have actually done for the ptsc sharehholder and you will see (IMO) why the price deteriorates. prior to tpl their accomplishments were zero. none. there is no management at PTSC. Management should have at least confronted or addressed the Dutton issue. they are silent. they hire pr companies and the good news we do get is a one pr "cookie cutter blurb". and then silence. there are so many positive things to consider with ptsc that promoting the company should be easy with a good pr company. the reality is we are the same company we were before tpl and the patent merger. the honeymoon of the potential patent revenue is over and the market wants meat. the market examines our leadership (bod) and ....well.....we throw them old bones.

T’moto


Dec 08, 2006 02:20AM
Share
New Message
Please login to post a reply